Xilio Therapeutics, Inc.

XLO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 76 employees
101
SEC Filings
$8.25
Close 2026-06-01
76
Employees

Business Summary

5 Item 1A. Risk Factors 36 Item 1B. Unresolved Staff Comments 95 Item 1C. Cybersecurity 95 Item 2. Properties 96 Item 3. Legal Proceedings 96 Item 4. Mine Safety Disclosures 96 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 97 Item 6. [Reserved] 97 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 98 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 112 Item 8...

Latest Stock Quote

XLO 2026-06-01 $8.25 O:$8.47 H:$8.53 L:$8.2 Vol:0.0M VWAP:$8.3463
origin leaf: 2360d0550d28728dff61feac4b25a30c55e3738c3ca673d7339af4bfea320cff

Next Earnings

Q2 FY2026 — expected 2026-09-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001193125-26-118550EDGAR120K words
2025-03-112024-12-310001558370-25-002640EDGAR
2024-04-012023-12-310001558370-24-004530EDGAR
2023-03-022022-12-310001558370-23-002687EDGAR
2022-03-012021-12-310001558370-22-002552EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-278837EDGAR81K words
2025-08-142025-06-300001558370-25-011477EDGAR
2025-05-082025-03-310001558370-25-006996EDGAR
2024-11-072024-09-300001558370-24-014775EDGAR
2024-08-082024-06-300001558370-24-011471EDGAR
2024-05-142024-03-310001558370-24-008068EDGAR
2023-11-092023-09-300001558370-23-018587EDGAR
2023-08-142023-06-300001558370-23-014711EDGAR
2023-05-092023-03-310001558370-23-008676EDGAR
2022-11-092022-09-300001558370-22-017018EDGAR
2022-08-092022-06-300001558370-22-012756EDGAR
2022-05-122022-03-310001558370-22-008441EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001193125-26-118544EDGAR3K words
2026-03-120001193125-26-103150EDGAR
2026-03-090001193125-26-097603EDGAR
2026-02-240001193125-26-065234EDGAR
2026-02-120001193125-26-048942EDGAR
2026-01-080001193125-26-007063EDGAR
2026-01-050001193125-26-001580EDGAR
2025-11-250001193125-25-297165EDGAR
2025-11-130001193125-25-278835EDGAR
2025-11-070001193125-25-271189EDGAR

101 total filings indexed. 74 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001840233
TickerXLO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.xiliotx.com
Listed2021-10-22

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f1ed9a03677e838090c0a24d930d4d9ddc238ba98e0dace2fff878679c599f78
parent: 80f2eebd8aaffc4ee706bf0560811dbe8aad025c6debb9e096c584e3ad13f11d
content hash: ca9bc6397bbc9c013d3a7fd5dd4c2f0f20c64a7795b95f33d8f53749997a3470
signed: 2026-06-03T12:03:06.654Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf